Current page: Home > ProductsProducts
Lysine clonixinate
Product name: Lysine clonixinateTo use: Medical intermediate
Executive standard:
Enterprise standard
Packaging: 25kg/drum
Packaging: ISO system
Place of origin: Baoji, Shaanxi
As a major manufacturer of methomonic acid, the company has purchased advanced equipment and instruments, and has innovatively developed the series of methomonic acid raw drug products: methomonic acid powder, granule, micro powder, heavy powder and other new products. The production process of this series of products is mature and has reached the international advanced level. It not only changes the situation of single specification of methamphetamine in the pharmaceutical market, fills the gap of diversified international market demand of methamphetamine raw material medicine, breaks the technical barrier of trade and the bottleneck of enterprise development, and is deeply favored and recognized by the majority of customers in the international market. In recent years, our company has established good long-term cooperative relations with some famous international companies, such as us Pfizer, France sanofi, Brazil novartis and other famous global pharmaceutical companies. They have included our company into the qualified suppliers of methacidine supply.
All of the mefenamic acid products are non - steroidal anti - inflammatory drugs. Non-steroidal anti-inflammatory drug can produce a moderate level of analgesic effect and the analgesic effect is mainly in the outer perimetis. It has good effect on chronic pain such as headache, joint and muscle pain and toothache. Anti-inflammatories are drugs that suppress inflammatory factors or release them. By inhibiting the production of inflammatory factors, it reduces the inflammation, and it reduces the pain that the inflammation can cause. Workshop equipment, facilities and other devices reach the domestic advanced technology level. The quality of products produced reached the international quality standards of European pharmacopoeia and British pharmacopoeia.
The company has many years production experience of API. Through the improvement of the existing products, the pollution to the environment has been greatly reduced. Through the research and application of new technologies and new processes, the company has become the world's largest producer of mefenamic acid raw materials, accounting for more than 75% of global exports.
